PropertyValue
?:abstract
  • We have read with great attention the article \'Coagulopathy in COVID-19\' written by Toshiaki Iba et al. (Authors), published in the September issue of Journal (1). The Authors performed an effective and informative review. Nevertheless, we welcome the opportunity to make a short comment as well. This very interesting article evaluates current literature regarding harmful hypercoagulable milieu of COVID-19. Surprisingly, we can not see that the Authors recommended other diagnostic considerations such a checking for hyperhomocysteinemia in patients with COVID-19. Undoubtedly, hyperhomocysteinemia has neurotoxic, neuroinflammatory, neurodegenerative, prooxidative, as well as proatherogenic/ prothrombotic effects.
?:creator
?:journal
  • J._thromb._haemost
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • COMMENT ON AN ARTICLE: \'Coagulopathy in COVID-19\'
?:type
?:who_covidence_id
  • #889792
?:year
  • 2020

Metadata

Anon_0  
expand all